Down-regulation of human protein kinase C alpha is associated with terminal neutrophil differentiation

Blood. 1992 Jul 1;80(1):68-76.

Abstract

We have established an RNase protection method to quantify the expression of mRNA for the human protein kinase C (PK-C) isoforms alpha, beta 1, beta 2, and gamma. This was used to investigate whether each isoform is differentially expressed during the differentiation of hematopoietic cells. Myeloid and lymphoid cells express PK-C alpha, beta 1, and beta 2 mRNAs in various proportions. PK-C gamma mRNA was detected in human brain, but not in hematopoietic cells. PK-C alpha mRNA decreases as HL-60 cells mature to a neutrophil phenotype in response to retinoic acid, but its abundance does not change during monocytic differentiation in response to vitamin D3. PK-C alpha mRNA and protein were undetectable in peripheral blood neutrophils, but are present in monocytes. The mRNAs for PK-C beta 1 and beta 2 isoforms increase during HL-60 differentiation and are expressed in both neutrophils and monocytes. Therefore, the PK-C alpha isoform is specifically down-regulated during human neutrophil terminal differentiation. These data suggest that mature neutrophil functions do not require the PK-C alpha isoform.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcitriol / pharmacology
  • Cell Differentiation / drug effects
  • Dimethyl Sulfoxide / pharmacology
  • Gene Expression
  • Hematopoietic Stem Cells / physiology*
  • Humans
  • In Vitro Techniques
  • Monocytes / cytology
  • Monocytes / enzymology
  • Neutrophils / cytology
  • Neutrophils / enzymology*
  • Protein Kinase C / genetics
  • Protein Kinase C / metabolism*
  • RNA, Messenger / genetics
  • Tretinoin / pharmacology
  • Tumor Cells, Cultured

Substances

  • RNA, Messenger
  • Tretinoin
  • Protein Kinase C
  • Calcitriol
  • Dimethyl Sulfoxide